SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-21-029626
Filing Date
2021-11-22
Accepted
2021-11-22 17:28:25
Documents
4
Period of Report
2021-11-22

Document Format Files

Seq Description Document Type Size
1 formdef14-a.htm DEF 14A 529877
2 formdef14-a_001.jpg GRAPHIC 8364
3 proxy_01.jpg GRAPHIC 104429
4 proxy_02.jpg GRAPHIC 92627
  Complete submission text file 0001493152-21-029626.txt   814250
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36268 | Film No.: 211433748
SIC: 2835 In Vitro & In Vivo Diagnostic Substances